s6y

LISATA THERAPEUTICS, INC.

Ticker
LSTA
CIK
320017
Industry
Pharmaceutical Preparations
Formerly
Caladrius Biosciences, Inc., CALADRIUS BIOSCIENCES, INC., NeoStem, Inc., PHASE III MEDICAL INC/DE, CORNICHE GROUP INC /DE

Financials 163

  1. 10-Q Quarterly Report for period ending Sep 30, 2026
  2. 10-Q Quarterly Report for period ending Jun 30, 2026
  3. 10-Q Quarterly Report for period ending Mar 31, 2026
  4. 10-K/A Annual Report for period ending Dec 31, 2025
  5. 10-K Annual Report for period ending Dec 31, 2025
  6. 10-Q Quarterly Report for period ending Sep 30, 2025
  7. 10-Q Quarterly Report for period ending Jun 30, 2025
  8. 10-Q Quarterly Report for period ending Mar 31, 2025
  9. 10-K Annual Report for period ending Dec 31, 2024
  10. 10-Q Quarterly Report for period ending Sep 30, 2024

All 163 financials filings

News 353

  1. 8-K/A Current report filing
  2. 8-K Current report filing
  3. 8-K/A Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 353 news filings

Ownership 708

  1. 3 Initial statement of beneficial ownership of securities
  2. 3 Initial statement of beneficial ownership of securities
  3. 3 Initial statement of beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 4 Statement of changes in beneficial ownership of securities
  8. 4 Statement of changes in beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. 4 Statement of changes in beneficial ownership of securities

All 708 ownership filings

Prospectus 154

  1. S-3/A Registration statement for specified transactions by certain issuers
  2. S-3 Registration statement for specified transactions by certain issuers
  3. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  4. SC TO-T/A Third party tender offer statement
  5. SC TO-T/A Third party tender offer statement
  6. SC TO-T/A Third party tender offer statement
  7. SC TO-T Third party tender offer statement
  8. SC TO-C Written communication relating to an issuer or third party tender offer
  9. SC TO-C Written communication relating to an issuer or third party tender offer
  10. SC TO-C Written communication relating to an issuer or third party tender offer

All 154 prospectus filings

Proxies 64

  1. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  2. DEF 14A Definitive proxy statements
  3. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  4. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  5. DEF 14A Definitive proxy statements
  6. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  7. DEF 14A Definitive proxy statements
  8. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  9. DEF 14A Definitive proxy statements
  10. DEF 14A Definitive proxy statements

All 64 proxies filings

Other 147

  1. ARS Annual report to security holders
  2. D Exempt (Private) Offering
  3. SCHEDULE 13G
  4. SC 14D9/A Tender offer solicitation/recommendation statements filed under Rule 14d-9
  5. SC 14D9/A Tender offer solicitation/recommendation statements filed under Rule 14d-9
  6. SC 14D9/A Tender offer solicitation/recommendation statements filed under Rule 14d-9
  7. SC 14D9/A Tender offer solicitation/recommendation statements filed under Rule 14d-9
  8. SC 14D9 Tender offer solicitation/recommendation statements filed under Rule 14d-9
  9. SC14D9C Written communication by the subject company relating to a third party tender offer
  10. SC14D9C Written communication by the subject company relating to a third party tender offer

All 147 other filings